Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med. 2007 Dec 27; 357(26):2666-76.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Phytogenic
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Breast Neoplasms
Disease Progression
Female
Humans
Middle Aged
Neoplasm Metastasis
Paclitaxel
Proportional Hazards Models
Quality of Life
Receptor, ErbB-2
Survival Analysis
authors with profiles
Melody Cobleigh